LOADING
Comparing Johnson & Johnson (JNJ) and Boeing Company (BA) across the Health Care and Industrials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | BA |
|---|---|---|
| Price | $270.24 | $214.20 |
| Change Today | +1.07% | -0.42% |
| Market Cap | $651.3B | $169.3B |
| P/E Ratio | 31.4 | 77.6 |
| Forward P/E | 23.2 | 3333.3 |
| PEG Ratio | 4.73 | 89.29 |
| EPS | $8.62 | $2.76 |
| Revenue Growth (YoY) | 6.6% | 8.0% |
| Profit Margin | 21.5% | 2.6% |
| Return on Equity | 25.7% | 173.5% |
| Dividend Yield | 1.96% | -- |
| Beta | 0.23 | 1.22 |
| 52-Week High | $276.47 | $254.35 |
| 52-Week Low | $170.33 | $176.77 |
| Volume | 6.2M | 6.2M |
Johnson & Johnson is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.